Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Substance Use Disorder
Policy
Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and Treatment
Testimony: Delivered to the United States Senate Committee on Finance
Print:
On May 23rd, 2024, Jeanmarie Perrone, MD testified during the U.S. Senate Committee on Finance’s hearing regarding the fentanyl crisis and combating addiction through prevention and treatment. Perrone offered federal strategies for consideration, such as lowering barriers and integrating care, increasing methadone access, and providing funding for harm-reduction services.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Projected Mortality Impacts of the Budget Reconciliation Bill
Research Memo: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Research Memo: Supplement to Response to Request for Technical Assistance
Medicaid’s Role in Health and the Health Care Landscape: Key Takeaways from LDI Researchers
Research Memo: Delivered to Staff of U.S. Senate Committee on Finance